Ambev (ABEV) Cash & Equivalents (2011 - 2026)

Ambev (ABEV) has 16 years of Cash & Equivalents data on file, last reported at $3.3 billion in Q2 2026.

• Quarterly Cash & Equivalents rose 13.26% year-over-year to $3.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.3 billion (up 13.26% YoY) and the FY2025 annual result came in at $3.5 billion, down 35.22% from the prior year.
• Cash & Equivalents declined to $3.3 billion in Q2 2026, from $3.5 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $4.9 billion in Q4 2024 to a low of $2.4 billion in Q1 2023.
• A 5-year average of $3.1 billion and a median of $3.2 billion in 2023 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2024 — Cash & Equivalents soared 51.69% — and 2025, when it dropped 29.74%.
• Tracing ABEV's Cash & Equivalents over 5 years: stood at $2.8 billion in 2022, then increased by 14.9% to $3.2 billion in 2023, then surged by 51.69% to $4.9 billion in 2024, then retreated by 29.74% to $3.5 billion in 2025, then slipped by 5.07% to $3.3 billion in 2026.
• The last three Cash & Equivalents figures came in at $3.3 billion (Q2 2026), $3.5 billion (Q4 2025), and $3.4 billion (Q3 2025), per Business Quant data.